» Articles » PMID: 14679171

Epithelial-mesenchymal Transition and Its Implications for Fibrosis

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2003 Dec 18
PMID 14679171
Citations 1151
Authors
Affiliations
Soon will be listed here.
Abstract

Epithelial to mesenchymal transition (EMT) is a central mechanism for diversifying the cells found in complex tissues. This dynamic process helps organize the formation of the body plan, and while EMT is well studied in the context of embryonic development, it also plays a role in the genesis of fibroblasts during organ fibrosis in adult tissues. Emerging evidence from studies of renal fibrosis suggests that more than a third of all disease-related fibroblasts originate from tubular epithelia at the site of injury. This review highlights recent advances in the process of EMT signaling in health and disease and how it may be attenuated or reversed by selective cytokines and growth factors.

Citing Articles

Psoriasis Treatments: Emerging Roles and Future Prospects of MicroRNAs.

Teo L, Juantuah-Kusi N, Subramanian G, Sampath P Noncoding RNA. 2025; 11(1).

PMID: 39997616 PMC: 11858470. DOI: 10.3390/ncrna11010016.


IFN-γ-mediated inhibition of JAK/STAT signaling via nano-scutellarin treatment is an efficient strategy for ameliorating liver fibrosis.

Wang T, Liu B, Huang J, Zhao Q, Shen H, Bi T J Transl Med. 2025; 23(1):195.

PMID: 39962553 PMC: 11834254. DOI: 10.1186/s12967-025-06155-5.


Radiotherapy Plus the Neurokinin-1 Receptor Antagonist Aprepitant: A Potent Therapeutic Strategy for the Treatment of Diffuse Intrinsic Pontine Glioma.

Munoz M, Rosso M Cancers (Basel). 2025; 17(3).

PMID: 39941886 PMC: 11816061. DOI: 10.3390/cancers17030520.


Conventional techniques and emerging nanotechnologies for early detection of cancer metastasis via epithelial-mesenchymal transition monitoring.

Zhang Z, Wang J, Wuethrich A, Trau M Natl Sci Rev. 2025; 12(3):nwae452.

PMID: 39926198 PMC: 11804803. DOI: 10.1093/nsr/nwae452.


Tumor microbiome: roles in tumor initiation, progression, and therapy.

Zhang S, Huang J, Jiang Z, Tong H, Ma X, Liu Y Mol Biomed. 2025; 6(1):9.

PMID: 39921821 PMC: 11807048. DOI: 10.1186/s43556-025-00248-9.


References
1.
ANDERS H, Schlondorff D . Murine models of renal disease: possibilities and problems in studies using mutant mice. Exp Nephrol. 2000; 8(4-5):181-93. DOI: 10.1159/000020667. View

2.
Jelaska A, Strehlow D, Korn J . Fibroblast heterogeneity in physiological conditions and fibrotic disease. Springer Semin Immunopathol. 2000; 21(4):385-95. View

3.
Rooman I, Heremans Y, Heimberg H, Bouwens L . Modulation of rat pancreatic acinoductal transdifferentiation and expression of PDX-1 in vitro. Diabetologia. 2000; 43(7):907-14. DOI: 10.1007/s001250051468. View

4.
von Kries J, Winbeck G, Asbrand C, Sochnikova N, DellOro A, Behrens J . Hot spots in beta-catenin for interactions with LEF-1, conductin and APC. Nat Struct Biol. 2000; 7(9):800-7. DOI: 10.1038/79039. View

5.
Boyer B, Valles A, Edme N . Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol. 2000; 60(8):1091-9. DOI: 10.1016/s0006-2952(00)00427-5. View